Eclectic enzymes: Easily modified building blocks for drug design

September 2, 2010
Eclectic enzymes: Easily modified building blocks for drug design

( -- In the pursuit of biologically active compounds, it is often necessary to be able to control the stereochemistry at predefined positions in a molecular skeleton. The search for ways to prepare chiral building blocks with known configuration that also show structural differentiation is important.

Italian scientists working with Elisabetta Brenna have developed a technique to separate individual stereoisomers of building blocks that can be easily integrated into biologically active molecules. As the scientists from Politecnico di Milano, Milano, Italy, report in the , their technique relies on the use of enzymes.

The specific activity of a biologically relevant molecule is often dependent on its stereochemistry (i.e., the spatial arrangement of its atoms). However, most compounds showing have complex structures, making their synthesis difficult. Moreover, compounds with differing stereochemistries can show different activities. Thus, it is sometimes desirable to prepare a range of compounds with the same structural backbone, but having different spatial arrangements of their atoms. The use of configurationally defined building blocks is attractive, but a method to obtain all the stereoisomers of a given building block is thus required.

Brenna and her colleagues have developed a method that allows a mixture of isomers to be differentiated, and it depends on the use of the enzyme lipase PS. The resolution of the stereoisomers relies on the preferential reaction of the enzyme with only one , thereby creating a product mixture containing the desired compound and a mixture of the unreacted isomers. The desired product can be easily separated from the unreacted mixture, which can then be resubjected to the enzyme to undergo further . In this way, a wide range of building blocks with differing and known stereochemistries can be prepared.

The authors then showed the applicability of their method by incorporating their configurationally defined building blocks into biologically active compounds. Using simple and straightforward organic chemistry transformations, the authors were able to embed their building blocks into two classes of compounds that are of biological interest. Importantly, scientists can now easily examine the biological activities of all the different stereoisomers of a given compound. Thus, the Italian team is well on their way to helping scientists screen a diverse range of potential drugs that may lead to the treatment, cure, prevention, or diagnosis of diseases.

Explore further: Molecular capsule: helical ribbon with closed ends takes up guest molecules

More information: Elisabetta Brenna, et al., Oxygenated Stereotriads with Definite Absolute Configuration by Lipase-Mediated Kinetic Resolution: De Novo Synthesis of Imino Sugars and 6-Deoxy-C-glycosides, European Journal of Organic Chemistry, 2010, No. 23, 4468-4475,

Related Stories

Minimal changes alter an enzyme dramatically

January 19, 2010

A new study by a research team at Uppsala University shows how new functions can develop in an enzyme. This can explain, for example, how resistance to toxins can occur so simply. The findings are now being published in the ...

Building blocks of the future

April 6, 2010

( -- Professor Varinder Aggarwal is no ordinary builder. He and his team in the School of Chemistry have just discovered a new technique that could hasten the development of new drugs for today’s incurable diseases ...

Recommended for you

A new form of real gold, almost as light as air

November 25, 2015

Researchers at ETH Zurich have created a new type of foam made of real gold. It is the lightest form ever produced of the precious metal: a thousand times lighter than its conventional form and yet it is nearly impossible ...

Getting under the skin of a medieval mystery

November 23, 2015

A simple PVC eraser has helped an international team of scientists led by bioarchaeologists at the University of York to resolve the mystery surrounding the tissue-thin parchment used by medieval scribes to produce the first ...

Moonlighting molecules: Finding new uses for old enzymes

November 27, 2015

A collaboration between the University of Cambridge and MedImmune, the global biologics research and development arm of AstraZeneca, has led researchers to identify a potentially significant new application for a well-known ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.